vs
诺唯真游轮控股（LINE）与Steris（STE）财务数据对比。点击上方公司名可切换其他公司
Steris的季度营收约是诺唯真游轮控股的1.1倍（$1.5B vs $1.4B），Steris净利率更高（12.9% vs -7.3%，领先20.2%），Steris同比增速更快（9.2% vs 3.1%），Steris自由现金流更多（$199.5M vs $35.0M）
诺唯真游轮控股是一家总部位于美国、注册地为百慕大的企业，旗下全资运营诺唯真游轮、大洋游轮、丽晶七海游轮三大品牌，合并业务规模位列全球游轮运营商第三位，目前在纽约证券交易所挂牌上市。
Steris plc是一家美爱合资的医疗设备企业，专注于为美国医疗体系提供灭菌服务及外科手术相关产品。其实际运营总部位于美国俄亥俄州门托市，深耕医疗消毒、感染防控、手术耗材等领域，为医疗机构提供专业可靠的医疗解决方案。
LINE vs STE — 直观对比
营收规模更大
STE
是对方的1.1倍
$1.4B
营收增速更快
STE
高出6.0%
3.1%
净利率更高
STE
高出20.2%
-7.3%
自由现金流更多
STE
多$164.5M
$35.0M
损益表 — Q3 FY2025 vs Q3 FY2026
| 指标 | | |
|---|---|---|
| 营收 | $1.4B | $1.5B |
| 净利润 | $-100.0M | $192.9M |
| 毛利率 | 32.3% | 43.8% |
| 营业利润率 | 2.5% | 18.3% |
| 净利率 | -7.3% | 12.9% |
| 营收同比 | 3.1% | 9.2% |
| 净利润同比 | 79.4% | 11.2% |
| 每股收益（稀释后） | $-0.44 | $1.96 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收LINESTE
| Q4 25 | — | $1.5B | ||
| Q3 25 | $1.4B | $1.5B | ||
| Q2 25 | $1.4B | $1.4B | ||
| Q1 25 | $1.3B | $1.5B | ||
| Q4 24 | $1.3B | $1.4B | ||
| Q3 24 | $1.3B | $1.3B | ||
| Q2 24 | $1.3B | $1.3B | ||
| Q1 24 | $1.3B | $1.1B |
净利润LINESTE
| Q4 25 | — | $192.9M | ||
| Q3 25 | $-100.0M | $191.9M | ||
| Q2 25 | $-6.0M | $177.4M | ||
| Q1 25 | $0 | $145.7M | ||
| Q4 24 | $-71.0M | $173.5M | ||
| Q3 24 | $-485.0M | $150.0M | ||
| Q2 24 | $-68.0M | $145.4M | ||
| Q1 24 | $-40.0M | $-1.4M |
毛利率LINESTE
| Q4 25 | — | 43.8% | ||
| Q3 25 | 32.3% | 44.2% | ||
| Q2 25 | 31.9% | 45.1% | ||
| Q1 25 | 32.2% | 43.3% | ||
| Q4 24 | 32.3% | 44.5% | ||
| Q3 24 | 32.8% | 43.6% | ||
| Q2 24 | 33.4% | 44.7% | ||
| Q1 24 | 33.4% | 40.2% |
营业利润率LINESTE
| Q4 25 | — | 18.3% | ||
| Q3 25 | 2.5% | 18.2% | ||
| Q2 25 | 1.7% | 17.7% | ||
| Q1 25 | 4.3% | 14.6% | ||
| Q4 24 | -1.6% | 17.9% | ||
| Q3 24 | -38.6% | 16.5% | ||
| Q2 24 | 5.5% | 14.5% | ||
| Q1 24 | 7.6% | 22.0% |
净利率LINESTE
| Q4 25 | — | 12.9% | ||
| Q3 25 | -7.3% | 13.1% | ||
| Q2 25 | -0.4% | 12.8% | ||
| Q1 25 | — | 9.8% | ||
| Q4 24 | -5.3% | 12.7% | ||
| Q3 24 | -36.3% | 11.3% | ||
| Q2 24 | -5.1% | 11.4% | ||
| Q1 24 | -3.0% | -0.1% |
每股收益（稀释后）LINESTE
| Q4 25 | — | $1.96 | ||
| Q3 25 | $-0.44 | $1.94 | ||
| Q2 25 | $-0.03 | $1.79 | ||
| Q1 25 | $0.01 | $1.48 | ||
| Q4 24 | $-0.52 | $1.75 | ||
| Q3 24 | $-2.44 | $1.51 | ||
| Q2 24 | $-0.46 | $1.46 | ||
| Q1 24 | $-0.28 | $-0.02 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | — | $423.7M |
| 总债务越低越好 | — | $1.9B |
| 股东权益账面价值 | $8.4B | $7.2B |
| 总资产 | $19.2B | $10.6B |
| 负债/权益比越低杠杆越低 | — | 0.27× |
8季度趋势，按日历期对齐
现金及短期投资LINESTE
| Q4 25 | — | $423.7M | ||
| Q3 25 | — | $319.2M | ||
| Q2 25 | — | $279.7M | ||
| Q1 25 | — | $171.7M | ||
| Q4 24 | $173.0M | $155.2M | ||
| Q3 24 | $409.0M | $172.2M | ||
| Q2 24 | $73.0M | $198.3M | ||
| Q1 24 | — | $207.0M |
总债务LINESTE
| Q4 25 | — | $1.9B | ||
| Q3 25 | — | $1.9B | ||
| Q2 25 | — | $1.9B | ||
| Q1 25 | — | $1.9B | ||
| Q4 24 | — | $2.0B | ||
| Q3 24 | — | $2.2B | ||
| Q2 24 | — | $2.2B | ||
| Q1 24 | — | $3.1B |
股东权益LINESTE
| Q4 25 | — | $7.2B | ||
| Q3 25 | $8.4B | $7.0B | ||
| Q2 25 | $8.6B | $7.0B | ||
| Q1 25 | $8.6B | $6.6B | ||
| Q4 24 | $8.6B | $6.4B | ||
| Q3 24 | $9.0B | $6.6B | ||
| Q2 24 | $4.9B | $6.4B | ||
| Q1 24 | $5.6B | $6.3B |
总资产LINESTE
| Q4 25 | — | $10.6B | ||
| Q3 25 | $19.2B | $10.4B | ||
| Q2 25 | $19.4B | $10.4B | ||
| Q1 25 | $18.8B | $10.1B | ||
| Q4 24 | $18.7B | $10.0B | ||
| Q3 24 | $19.3B | $10.2B | ||
| Q2 24 | $18.8B | $10.1B | ||
| Q1 24 | — | $11.1B |
负债/权益比LINESTE
| Q4 25 | — | 0.27× | ||
| Q3 25 | — | 0.27× | ||
| Q2 25 | — | 0.27× | ||
| Q1 25 | — | 0.29× | ||
| Q4 24 | — | 0.32× | ||
| Q3 24 | — | 0.33× | ||
| Q2 24 | — | 0.35× | ||
| Q1 24 | — | 0.50× |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $230.0M | $298.2M |
| 自由现金流经营现金流 - 资本支出 | $35.0M | $199.5M |
| 自由现金流率自由现金流/营收 | 2.5% | 13.3% |
| 资本支出强度资本支出/营收 | 14.2% | 6.6% |
| 现金转化率经营现金流/净利润 | — | 1.55× |
| 过去12个月自由现金流最近4个季度 | — | $917.1M |
8季度趋势，按日历期对齐
经营现金流LINESTE
| Q4 25 | — | $298.2M | ||
| Q3 25 | $230.0M | $287.8M | ||
| Q2 25 | $258.0M | $420.0M | ||
| Q1 25 | $139.0M | $260.8M | ||
| Q4 24 | — | $332.8M | ||
| Q3 24 | $186.0M | $250.7M | ||
| Q2 24 | $155.0M | $303.7M | ||
| Q1 24 | $105.0M | $254.8M |
自由现金流LINESTE
| Q4 25 | — | $199.5M | ||
| Q3 25 | $35.0M | $201.3M | ||
| Q2 25 | $95.0M | $326.4M | ||
| Q1 25 | $-12.0M | $189.9M | ||
| Q4 24 | — | $243.6M | ||
| Q3 24 | $33.0M | $148.8M | ||
| Q2 24 | $-31.0M | $195.7M | ||
| Q1 24 | $-42.0M | $163.3M |
自由现金流率LINESTE
| Q4 25 | — | 13.3% | ||
| Q3 25 | 2.5% | 13.8% | ||
| Q2 25 | 7.0% | 23.5% | ||
| Q1 25 | -0.9% | 12.8% | ||
| Q4 24 | — | 17.8% | ||
| Q3 24 | 2.5% | 11.2% | ||
| Q2 24 | -2.3% | 15.3% | ||
| Q1 24 | -3.2% | 14.6% |
资本支出强度LINESTE
| Q4 25 | — | 6.6% | ||
| Q3 25 | 14.2% | 5.9% | ||
| Q2 25 | 12.1% | 6.7% | ||
| Q1 25 | 11.7% | 4.8% | ||
| Q4 24 | — | 6.5% | ||
| Q3 24 | 11.5% | 7.7% | ||
| Q2 24 | 13.9% | 8.4% | ||
| Q1 24 | 11.1% | 8.2% |
现金转化率LINESTE
| Q4 25 | — | 1.55× | ||
| Q3 25 | — | 1.50× | ||
| Q2 25 | — | 2.37× | ||
| Q1 25 | — | 1.79× | ||
| Q4 24 | — | 1.92× | ||
| Q3 24 | — | 1.67× | ||
| Q2 24 | — | 2.09× | ||
| Q1 24 | — | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
LINE
| Warehousing Operations | $883.0M | 64% |
| Other | $308.0M | 22% |
| Warehouse Lease | $60.0M | 4% |
| Food Sales | $52.0M | 4% |
| E Commerce And Other | $46.0M | 3% |
| Railcar Lease | $23.0M | 2% |
| Service Other | $5.0M | 0% |
STE
| Servicerevenues | $404.7M | 27% |
| Consumablerevenues | $387.1M | 26% |
| Applied Sterilization Technologies | $286.6M | 19% |
| Capitalequipmentrevenues | $272.1M | 18% |
| Life Science | $145.8M | 10% |
